These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 1096801)

  • 21. Amphotericin B and 5-fluorocytosine penetration into blood and fibrin clots.
    Rubinstein E
    Chemotherapy; 1979; 25(5):249-53. PubMed ID: 573195
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sensitivity of Candida to 5-fluorocytosine and amphotericin B].
    Pawlik B; Budak A; Macura A; Laskownicka Z
    Med Dosw Mikrobiol; 1978; 30(1):43-8. PubMed ID: 692181
    [No Abstract]   [Full Text] [Related]  

  • 23. The effect of 5-fluorocytosine on the blastospores and hyphae of Candida albicans.
    Polak A; Wain WH
    J Med Microbiol; 1979 Feb; 12(1):83-97. PubMed ID: 372535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
    Högl F; Raab W
    Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
    [No Abstract]   [Full Text] [Related]  

  • 25. Laboratory methods for flucytosine (5-fluorocytosine). Report of a Working Group of the British Society for Mycopathology.
    J Antimicrob Chemother; 1984 Jul; 14(1):1-8. PubMed ID: 6480540
    [No Abstract]   [Full Text] [Related]  

  • 26. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
    Paniagua GL; Monroy E; Negrete E; Vaca S
    Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro susceptibilities of sucrose-negative Candida tropicalis, Candida lusitaniae, and Candida norvegensis to amphotericin B, 5-fluorocytosine, miconazole, and ketoconazole.
    Ahearn DG; McGlohn MS
    J Clin Microbiol; 1984 Mar; 19(3):412-6. PubMed ID: 6325491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Results of combined treatment with 5-fluorocytosine (5FC) and amphoterycine B in a case of cerebrospinal meningitis due to Candida albicans in an infant.
    Krupińska-Sanecka I; Fracka B; Janik A; Bodarski Z; Kowalik B
    Mater Med Pol; 1985; 17(4):246-9. PubMed ID: 3834262
    [No Abstract]   [Full Text] [Related]  

  • 29. Clearance of amphotericin B and 5-fluorocytosine by peritoneal dialysis.
    Muther RS; Bennett WM
    Proc Clin Dial Transplant Forum; 1979; 9():100-1. PubMed ID: 552029
    [No Abstract]   [Full Text] [Related]  

  • 30. [Synergistic action of amphotericin B and 5-fluorocytosine on Fonsecaea pedrosoi].
    de Resende MA
    Rev Inst Med Trop Sao Paulo; 1979; 21(6):344-6. PubMed ID: 550288
    [No Abstract]   [Full Text] [Related]  

  • 31. [In vitro sensitivity to 5-fluorocytosine and amphotericin B of yeasts of the Candida genus isolated in Barcelona].
    Torres-Rodríguez JM; Sabaté M; Gallach C; Carrillo A; Madrenys N
    Enferm Infecc Microbiol Clin; 1990 Feb; 8(2):91-3. PubMed ID: 2098147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Disseminated candidiasis due to amphotericin B-resistant Candida albicans.
    Conly J; Rennie R; Johnson J; Farah S; Hellman L
    J Infect Dis; 1992 Apr; 165(4):761-4. PubMed ID: 1285732
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro determination of optimal antifungal combinations against Cryptococcus neoformans and Candida albicans.
    Ghannoum MA; Fu Y; Ibrahim AS; Mortara LA; Shafiq MC; Edwards JE; Criddle RS
    Antimicrob Agents Chemother; 1995 Nov; 39(11):2459-65. PubMed ID: 8585726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B.
    Calhoun DL; Roberts GD; Galgiani JN; Bennett JE; Feingold DS; Jorgensen J; Kobayashi GS; Shadomy S
    J Clin Microbiol; 1986 Feb; 23(2):298-301. PubMed ID: 3517051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of microdilution and broth dilution techniques for the susceptibility testing of yeasts to 5-fluorocytosine and amphotericin B.
    Mazens MF; Andrews GP; Bartlett RC
    Antimicrob Agents Chemother; 1979 Mar; 15(3):475-7. PubMed ID: 464576
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
    Costa AL; Valenti A; Costa G; Calogero F
    G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro interaction of flucytosine combined with amphotericin B or fluconazole against thirty-five yeast isolates determined by both the fractional inhibitory concentration index and the response surface approach.
    Te Dorsthorst DT; Verweij PE; Meletiadis J; Bergervoet M; Punt NC; Meis JF; Mouton JW
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2982-9. PubMed ID: 12183257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid microbiological assay for 5-fluorocytosine.
    Schiavone DJ; Page MD; Dawborn JK
    Br Med J; 1973 Nov; 4(5889):380-2. PubMed ID: 4584231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of Amphotericin-B, 5-fluorocytosine and Nystatin on Histoplasma farciminosum in vitro.
    Gabal MA
    Zentralbl Veterinarmed B; 1984 Feb; 31(1):46-50. PubMed ID: 6720163
    [No Abstract]   [Full Text] [Related]  

  • 40. Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine.
    Pfaller MA; Bale M; Buschelman B; Lancaster M; Espinel-Ingroff A; Rex JH; Rinaldi MG; Cooper CR; McGinnis MR
    J Clin Microbiol; 1995 May; 33(5):1104-7. PubMed ID: 7615713
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.